A novel targeted immunotherapy for autoreactive B cell depletion in autoimmune diseases

Luca Perico; Federica Casiraghi; Fabiane Sônego; Marta Todeschini; Daniela Corna; Domenico Cerullo; Anna Pezzotta; Patricia Isnard‐Petit; Silvia Faravelli; Federico Forneris; Kader Thiam; Giuseppe Remuzzi; Ariela Benigni

doi:10.21203/rs.3.rs-3042909/v2

Article2024

Bi-specific autoantigen-T cell engagers as targeted immunotherapy for autoreactive B cell depletion in autoimmune diseases

Luca Perico, Federica Casiraghi, Fabiane Sônego, Marta Todeschini, Daniela Corna, Domenico Cerullo, Anna Pezzotta, Patricia Isnard‐Petit, Silvia Faravelli, Federico Forneris, Kader Thiam, Ariela Benigni, Giuseppe Remuzzi

Preprint2023

Bi-specific AutoAntigen-T cell Engagers as targeted immunotherapy for autoreactive B cell depletion in autoimmune diseases

Luca Perico, Federica Casiraghi, Fabiane Sônego, Marta Todeschini, Daniela Corna, Domenico Cerullo, Anna Pezzotta, Patricia Isnard‐Petit, Silvia Faravelli, Federico Forneris, Kader Thiam, Giuseppe Remuzzi, Ariela Benigni

Corrigendum2025

Corrigendum: Bi-specific autoantigen-T cell engagers as targeted immunotherapy for autoreactive B cell depletion in autoimmune diseases

Luca Perico, Federica Casiraghi, Fabiane Sônego, Marta Todeschini, Daniela Corna, Domenico Cerullo, Anna Pezzotta, Patricia Isnard‐Petit, Silvia Faravelli, Federico Forneris, Kader Thiam, Ariela Benigni, Giuseppe Remuzzi

Letter2013

A beneficial effect of rituximab on autoimmune thrombotic thrombocytopenic purpura: Just a B-cell depletion?

Jae Il Shin, Michael Eisenhut

Article2025

Is there a place for engineered immune cell therapies in autoimmune diseases?

Luca Perico, Federica Casiraghi, Ariela Benigni, Giuseppe Remuzzi

A novel targeted immunotherapy for autoreactive B cell depletion in autoimmune diseases

Discussion(0)

Open reviews(0)

Related publications

Bi-specific autoantigen-T cell engagers as targeted immunotherapy for autoreactive B cell depletion in autoimmune diseases

Bi-specific AutoAntigen-T cell Engagers as targeted immunotherapy for autoreactive B cell depletion in autoimmune diseases

Corrigendum: Bi-specific autoantigen-T cell engagers as targeted immunotherapy for autoreactive B cell depletion in autoimmune diseases

A beneficial effect of rituximab on autoimmune thrombotic thrombocytopenic purpura: Just a B-cell depletion?

Is there a place for engineered immune cell therapies in autoimmune diseases?